Dr Steven Bradshaw: LEADING DRUGS INDUSTRY ACQUISITIONS EXPERT SAYS ASTRAZENECA TAKEOVER COULD BE GOOD NEWS FOR NHS
London, UK: DR STEVEN BRADSHAW URGES CRITICS TO SEE BENEFITS - TO STAKEHOLDERS, HEALTHCARE PROVIDERS AND PATIENTS
It’s the UK economy’s largest ever takeover - and one that has attracted widespread concern.
But now a leading drugs industry acquisitions expert is urging politicians to see the benefits of the AstraZeneca/Pfizer merger
Dr Steven Bradshaw, who advises major pharmaceutical companies on drug pricing, market access and portfolio evaluations, says the takeover could be a good thing for Britain and the NHS.
As he says: “Although the government sees this merger as being a potential major loss for the economy, it could be a valuable process in other ways and teach us key lessons about our own future healthcare provision.”
“Perhaps rather than leaning on private enterprise to help keep us out of recession, the government and public sector can learn from the strategic thinkers and success stories within big corporations.”
“Often it’s more about how money is invested than the amounts involved.”
“The NHS is a prime example of an organisation that can be made leaner and thus more efficient and more effective within its existing budget.”
As merger talks continue, Dr Bradshaw goes on to urge co-operation between the parties,
“Instead of attacking industry head-on it might be better to think about how agreement can be reached between all stakeholders,” he explains.
“Aggressive engagement isn’t going to work because it doesn’t take into account the interests of these two companies.”
“Part of due diligence involves assessing the environment and market. Pfizer is now in the process of negotiating the fine detail with AstraZeneca and the last thing that they need is an unwelcoming attitude from the very country that they are considering investing in.“
“It is very possible that the merger could be a start of a new chapter in the fight against disease and for the UK's pharma industry, so let’s make sure that clumsy politics don’t get in the way.”
clairedonnelli@gmail.com
07538 000271
Dr Steven Bradshaw is an expert industry advisor on pricing, market access strategy and portfolio evaluations in the health technology sector.
Tags:
